Client & Alumni News

Saladax Biomedical – Large Study Confirms the Benefit of Advanced Dosing Method for Chemotherapy

Saladax Biomedical, Inc. recently presented results from the largest randomized, prospective dose adjustment-therapeutic drug monitoring trial ever conducted in oncology. The majority of patients saw a significant reduction in the chemotherapy dose with fewer toxic side effects and the same survival rate. Read more: